Your session is about to expire
← Back to Search
Virtual Mindfulness-Based Intervention for Depression (RECLAIM Trial)
RECLAIM Trial Summary
This trial will test if mindfulness can help Veterans reduce depression & better adjust to life after service.
RECLAIM Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.RECLAIM Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am a veteran aged between 18 and 44.I am a veteran and have some difficulty adjusting to civilian life.
- Group 1: Psychoeducation materials only
- Group 2: RECLAIM intervention
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Who is eligible to participate in this medical research?
"Individuals aged between 18-44, who are clinically diagnosed with depression, can apply to this study. Currently the team is looking for 48 patients to take part in it."
Is the upper age limit for this clinical research fixed at 70 years?
"This medical research seeks participants aged 18 to 44 years old. For those below the age of consent, there are 196 other trials they may participate in; for individuals 65 and older, 864 studies are available."
Are recruitment efforts for this research project still active?
"According to clinicaltrials.gov, this particular trial has ceased recruitment; the initial post date was November 1st 2023 whilst the last update was on July 26th 2023. Fortunately, there are 1181 other trials actively searching for enrolment currently."
Who else is applying?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger